A very recent study which investigated the effects of dietary EPA and DHA supplementation on the nutritional inflammatory status and long-term survival of patients with acute and chronic leukemia and lymphomas (Hodgkin and Non-Hodgkin lymphomas) receiving chemotherapy revealed that the consumption 2 g/day of fish oil (containing EPA and DHA) for 9 months resulted in greater reduction in the C-reactive protein (CRP) and CRP/albumin ratio in the patients receiving the supplement and chemotherapy in comparison to those receiving chemotherapy only. The gene discussed is ALB; the disease is non-Hodgkin lymphoma.